Related Experiment Video

Updated: Jun 12, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K

The rise of antibody-drug conjugates in advanced endometrial cancer

Mariana Carvalho Gouveia1, Thamires Haick Martins da Silveira2, Mariana Scaranti3

  • 1Hospital 9 de Julho, São Paulo, São Paulo, Brazil marianacgouveia@gmail.com.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|September 23, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Endometrial Neoplasms

More Related Videos

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.7K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K

Related Experiment Videos

Last Updated: Jun 12, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.7K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Immunotherapy-Associated Autoimmune Hemolytic Anemia: Two Case Reports and a Literature Review.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study.

Journal of gastrointestinal oncology·2025

Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancer.

NPJ breast cancer·2025

Breast and gynecologic cancers as a Brazilian health priority.

Revista da Associacao Medica Brasileira (1992)·2023

Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.

Clinical cancer research : an official journal of the American Association for Cancer Research·2020

Urinary procedures in gynecologic oncology: a comprehensive literature review and management algorithm proposal.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Not all artificial intelligence large language models are created equal: heterogeneous performance in therapeutic decision-making for recurrent epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Early experience with mirvetuximab soravtansine in the treatment of recurrent low- grade serous ovarian carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

BEHOLD-1 and -2: phase 1/2 randomized studies evaluating the B7 homolog 4 protein-targeted antibody-drug conjugate mocertatug rezetecan in patients with solid tumors, including endometrial and ovarian cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Predicting high-grade lesions and cervical cancer with supervised machine learning algorithms.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

PARAGON-II cohort C: a phase II basket study of letrozole plus ribociclib in hormone receptor-positive, platinum-resistant, high-grade epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Calreticulin and myeloproliferative neoplasms: linking biology to targeted therapies.

Expert review of clinical immunology·2026

Plant cytokinin ortho-topolin riboside suppresses the proliferation of multiple myeloma cells by promoting β-catenin degradation.

BMB reports·2026

MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

TRPM4 promotes ErSO-mediated oncosis-like cell death in prostate cancer cells.

Cancer research communications·2026

NEK2 Promotes OSCC Invasion and Metastasis by Activating TNF-α Signaling Through Impairment of Desmosomal Adhesion.

BioFactors (Oxford, England)·2026

Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma.

Journal of translational medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us